FDA Announces Class II Recall of Amgen's Corlanor and Sensipar Due to Foreign Substances

The FDA has announced a Class II recall initiated by Amgen for over 944,000 bottles of its heart medication Corlanor (ivabradine) and kidney medication Sensipar (cinacalcet). The recall is due to the presence of foreign substances, though health officials have determined the risk to the public is low, indicating temporary or reversible adverse health consequences are possible.